Stockscreener 앱 받기
10.60
0.19%
0.02
전일 마감가:
$10.58
열려 있는:
$10.415
하루 거래량:
3,166
Relative Volume:
0.19
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.57%
1개월 성능:
+2.81%
6개월 성능:
+5.68%
1년 성능:
+0.00%
1일 변동 폭
$10.41
$10.90
1주일 범위
$10.41
$10.90
52주 변동 폭
$9.99
$10.90
Oaktree Acquisition Corp Iii Life Sciences Stock (OACCU) Company Profile
명칭
Oaktree Acquisition Corp Iii Life Sciences
전화
213-830-6300
주소
333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES
OACCU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OACCU
Oaktree Acquisition Corp Iii Life Sciences
|
10.60 | 0 | 0 | 0 | 0 | 0.00 |
|
GIBO
Gibo Holdings Ltd
|
3.9617 | 5.13B | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
7.075 | 1.94B | 0 | 0 | 0 | 0.00 |
|
AACT
Ares Acquisition Corporation Ii
|
11.27 | 696.54M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.73 | 462.30M | 0 | 1.30M | 0 | 0.0301 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.24 | 455.09M | 0 | 0 | 0 | 0.00 |
Oaktree Acquisition Corp Iii Life Sciences 주식(OACCU)의 최신 뉴스
195,292 Shares in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Acquired by K2 Principal Fund L.P. - MarketBeat
AQR Arbitrage LLC Invests $19.74 Million in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) - MarketBeat
Shaolin Capital Management LLC Makes New Investment in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) - MarketBeat
Hingham Institution for Savings (NASDAQ:HIFS) Sees Strong Trading Volume After Dividend Announcement - The AM Reporter
Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update - GlobeNewswire Inc.
Investors Buy High Volume of Call Options on Hallador Energy (NASDAQ:HNRG) - Defense World
Jet2 plc (OTCMKTS:DRTGF) Sees Significant Growth in Short Interest - Defense World
Sagicor Financial Company Ltd. (OTCMKTS:SGCFF) Short Interest Update - Defense World
With 59% ownership, Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) boasts of strong institutional backing - Yahoo
The Roundup: Top Takeaways from Oaktree’s Quarterly Letters – March 2025 Edition - Oaktree Capital Management
OAKTREE ACQUISITION CORP III LIFE SCIENCES- The GF Score's 5 Key Aspects of Analysis - GuruFocus
Verona Pharma Lands Massive $450M Financing Deal as COPD Drug Success Drives Growth - Stock Titan
Tesla, Oaktree among Tuesday’s market cap stock movers - Investing.com Australia
Oaktree Capital-backed TSG adds on NLIST - PE Hub
Tesla, Oaktree among Tuesday’s market cap stock movers By Investing.com - Investing.com UK
Tesla, Applovin Lead Market Cap Stock Movers on Thursday - Investing.com Australia
Tesla, Applovin Lead Market Cap Stock Movers on Thursday By Investing.com - Investing.com Nigeria
Morgan Sindall takes over Canary Wharf lab job - Construction Index
Morgan Sindall takes life sciences job after ISG collapse - Construction News
Private equity drives dealmaking across sectors with $870m+ in disclosed transactions - Alternatives Watch
ICR, the Leading SPAC Communications and Advisory Firm, Publishes its Yearend 2024 SPAC Market Update & Outlook - Business Wire
Indivior finance chief quits board role as drugmaker settles Oaktree row - This is Money
The Roundup: Top Takeaways from Oaktree’s Quarterly Letters – December 2024 Edition - Oaktree Capital Management
Oaktree Acquisition Corp. III Announces Unit Separation, Nasdaq Trading Updates for December - StockTitan
Oaktree Acquisition Corp. III Life Sciences Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing December 16, 2024 - Business Wire
OACCU News Today | Why did Oaktree Acquisition Corp. III Life Sciences stock go up today? - MarketBeat
Oaktree Acquisition Corp. III Life Sciences’ (NASDAQ:OACCU) Quiet Period Will End on December 3rd - Defense World
Pacific Valley Bancorp (OTCMKTS:PVBK) and Pinnacle Financial Partners (NASDAQ:PNFP) Critical Comparison - Defense World
Trinity Investments Acquires The Standard, London Alongside Oaktree and Partners Group - Business Wire
Oaktree Acquisition Corp. III Life Sciences’ US$175 Million Initial Public Offering - Global Legal Chronicle
White & Case advises underwriters on Oaktree Acquisition Corp. III Life Sciences’ US$175 million IPO - White & Case LLP
U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha
Oaktree Acquisition Corp. III Life Sciences Announces Pricing of $175 Million Initial Public Offering - Business Wire
Deal Watch: Big Week for Private Equity, Private Credit and Kirkland - Law.com
Battle for Oaktree’s €200m+ Irish portfolio reignites - Green Street News
B. Riley to sell Great American unit to Oaktree in $386 mln deal - Reuters
Oaktree creates third life sciences SPAC, following success with Hims & Hers and Alvotech - Endpoints News
IPO NewsUS IPO Weekly Recap: Standard Aero soars in 7-IPO week, while big tech names join pipeline - renaissancecapital.com
Envestnet approves Bain acquisition, Warburg Pincus leads $125m Series E - Alternatives Watch
Nordic PE firm Adelis Equity Partners comes calling for Melbourne life sciences biz IonOpticks - The Australian Financial Review
Oaktree Assumes Ownership of Inter Milan - Business Wire
Ilir Mujalovic - A&O Shearman
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS - GlobeNewswire
Exclusive | Oaktree Spins Out Transportation-Infrastructure Group - WSJ
Special Purpose Acquisition Companies - Ropes & Gray LLP
Private Credit Funds Get Moody’s Warning on Problem Loans - Bloomberg
Ares Takes Fresh Aim at Healthcare Through New Fund - WSJ
IRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in Columbus - Newsfile
PE Weekly: Investment Bank Spins Out a New PE Firm - Middle Market Growth
LPW Group Partners with Oaktree - Business Wire
Forest Road Taps Kramer as President - Los Angeles Business Journal
Oaktree Acquisition Corp Iii Life Sciences (OACCU) 재무 분석
Oaktree Acquisition Corp Iii Life Sciences (OACCU)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.00%
0.05%
자본화:
|
볼륨(24시간):